SCHEMBL6469392

SCHEMBL6469392

[CH2][N]N(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5958240 0.69
SCHEMBL9130128 0.62
N-Nitrosodiethylamine SCHEMBL106629 0.61
SCHEMBL5958237 0.61
SCHEMBL8910054 0.56
SCHEMBL5419127 0.56
SCHEMBL31301155 0.56
SCHEMBL64854 0.56
SCHEMBL22809109 0.54
N,N-Dimethylethanaminium SCHEMBL8763167 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050203045-A1 Antisense modulation of cellular inhibitor of Apoptosis-2 expression BENNETT C F (US) 2005-09-15 US disclosed
WO-2002010409-A1 ANTISENSE INHIBITION OF HER-3 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2002-02-07 WO disclosed